Subscribe
Close
  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Renew

PTS Diagnostics Plans Headquarters in Indianapolis, Indiana

05/29/2018
PTS Diagnostics, a manufacturer of point-of-care biometric testing devices, is expanding operations and building a new global headquarters in Indianapolis, Indiana.

In order to support continued rapid growth, the in vitro diagnostics company is investing in additional manufacturing and office space, and moving their global headquarters to Whitestown. The new 135,000 square foot building is slated to open in June of 2019 on the southwest corner of Anson Blvd and C.R. 450 South.

A private groundbreaking ceremony with executives, architects, builders and representatives from PTS Diagnostics’ parent company, Sinocare, was held on the morning of Tuesday, May 15. A company-wide celebration is planned for summer 2018.“PTS Diagnostics is still in high-growth mode, and our organization has evolved considerably in the past decade,” said Robert Huffstodt, President & CEO of PTS Diagnostics. “As an organization, we pride ourselves on the ability to adhere to our core Hoosier values while scaling the business globally in accordance with growing demand and the expansion of our product lines.”

“In addition to acquiring a manufacturing facility in California, we recently opened a sales office in Bangalore, India. In December, we announced the launch of a new retail point-of-care software for health screeners that is poised to create a niche in the expanding field of population health management,” he said.

“The Browning/Duke Realty joint venture is proud to partner with PTS Diagnostics and assist them with the development of a building that is capable of meeting their growth and manufacturing needs, said Mark Hosfeld, Vice President of Leasing and Development at Duke Realty. “Indiana has a booming life sciences sector and this new global headquarters represents a continued commitment to the point-of-care technology that will further solidify their place in this rapidly growing industry.”

Article Discussion

Share